Approvals/TGA/ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection flange extender

Approved

STANDARD

ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection flange extender

Bristol-Myers Squibb Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d6c8402c5d63d637
Product Name: ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection flange extender
Artg Id: 177176
Artg Name: ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection flange extender
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path: /organization/bristol-myers-squibb-australia-pty-ltd
Artg Date: 2012-01-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03513-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

d6c8402c5d63d637

Type

Standard